Fain v. Crouch

District Court, S.D. West Virginia·Decided June 28, 2021·No. 3:20-cv-00740·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA

HUNTINGTON DIVISION

CHRISTOPHER FAIN; ZACHARY MARTELL; and BRIAN MCNEMAR, individually and on behalf of all others similarly situated,

Plaintiffs,

v. CIVIL ACTION NO. 3:20-0740

WILLIAM CROUCH, in his official capacity as Cabinet Secretary of the West Virginia Department of Health and Human Resources; CYNTHIA BEANE, in her official capacity as Commissioner for the West Virginia Bureau for Medical Services; WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES, BUREAU FOR MEDICAL SERVICES; TED CHEATHAM, in his official capacity as Director of the West Virginia Public Employees Insurance Agency; and THE HEALTH PLAN OF WEST VIRGINIA, INC.,

Defendants.

MEMORANDUM OPINION AND ORDER Pending before the Court is The Health Plan of West Virginia’s Motion to Dismiss (ECF No. 20). For the following reasons, the motion is DENIED. I. BACKGROUND Plaintiffs’ sole claim against The Health Plan is discrimination in violation of Section 1557 of the Patient Protection and Affordable Care Act. Section 1557 (also known as the ACA’s “nondiscrimination provision”) prohibits discrimination under “any health program or activity, any part of which is receiving Federal financial assistance, including credits, subsidies, or contracts of insurance . . . . ” 42 U.S.C. § 18116. As previously detailed in this Court’s May 19, 2021, Memorandum Opinion and Order (ECF No. 57), Plaintiffs Brian McNemar and Zachary Martell allege that The Health Plan’s policy excluding gender-confirming care discriminates against transgender individuals. The Health Plan now seeks dismissal of this claim under Federal Rule of Civil Procedure 12(b)(6).

II. DISCUSSION The crux of the parties’ dispute is about the scope of Section 1557, and in particular, the meaning of “any health program or activity.” The scope of this language has a sharply disputed administrative history. In 2016, the Obama Administration promulgated a final rule which interpreted Section 1557 to expressly include health insurance issuers: “‘health program or activity’ must be interpreted in a manner that uniformly covers all of the operations of any entity that receives Federal financial assistance and that is principally engaged in . . . health insurance coverage . . . . ” 81 Fed. Reg. 31376, 31386 (2016). But in 2020, the Trump Administration finalized a rule repealing that definition and

narrowing Section 1557 to entities “principally engaged in the business of providing healthcare.” 85 Fed. Reg. 37160, 37172 (2020) (“2020 Rule”). The Trump Administration further limited Section 1557 by determining that health insurance issuers are not “principally or otherwise engaged in the business of healthcare.” Id.; 45 C.F.R. § 92.3(b)-(c).1 Having construed Section

1 The regulation resulting from the 2020 Rule, 45 C.F.R. § 92.3(b)-(c) (2020), states: (b) As used in this part, “health program or activity” encompasses all of the operations of entities principally engaged in the business of providing healthcare that receive Federal financial assistance as described in paragraph (a)(1) of this section. For any entity not principally engaged in the business of providing healthcare, the requirements applicable to a “health program or activity” under this part shall apply to such entity's operations only to the extent any such operation receives Federal financial assistance as described in paragraph (a)(1) of this section. (c) For purposes of this part, an entity principally or otherwise engaged in the 1557 to exclude health insurance issuers like The Health Plan, the 2020 Rule provides that such entities are prohibited from discriminating against individuals “only to the extent any such operation receives Federal financial assistance.” Id. at (b). Although the 2020 Rule remains in effect, Plaintiffs argue that it does not control this Court’s analysis because Section 1557’s plain text unambiguously prohibits discrimination by The

Health Plan under its entire portfolio. The Court agrees with Plaintiffs and declines to defer to the 2020 Rule. 2 When determining whether deference to an agency interpretation is owed, the Court must apply the two-step analysis under Chevron U.S.A. Inc. v. Nat. Res. Def. Council, Inc., 467 U.S. 837 (1984). The first step considers “whether Congress has directly spoken to the precise question at issue.” Id. at 842. If so, “that is the end of the matter; for the court, as well as the agency, must give effect to the unambiguously expressed intent of Congress.” Id. at 842-43. “However, if the statute is silent or ambiguous in expressing Congress’ intent,” the court must “defer to the agency’s reasonable construction of the statute.” Id. at 843-44. Although this analysis focuses on the statute

at issue, “a reviewing court should not confine itself to examining a particular statutory provision in isolation. Rather, [t]he meaning—or ambiguity—of certain words or phrases may only become evident when placed in context.” King v. Burwell, 759 F.3d 358, 368-69 (4th Cir. 2014), aff’d, 576 U.S. 473 (2015) (quoting Nat’l Ass’n of Home Builders v. Defs. of Wildlife, 551 U.S. 644, 666

business of providing health insurance shall not, by virtue of such provision, be considered to be principally engaged in the business of providing healthcare. 2 As best this Court can tell, this issue is one of first impression. Although several courts have considered challenges to the 2020 Rule, none have addressed whether its interpretation of “health program or activity” must be granted Chevron deference. At least one court has concluded that Section 1557 is ambiguous under Chevron step one. See Callum v. CVS Health Corp., 137 F. Supp. 3d 817 (D. S.C. 2015). However, in that case, the court did not consider whether an insurance issuer could be held liable under Section 1557 and instead applied the law to pharmacies. Id. at 850. (2007)) (internal citation and quotation marks omitted). If the Court concludes that the statute is ambiguous, it must turn to whether the regulation is a permissible interpretation. The Fourth Circuit has held that agency interpretations carry controlling weight unless they are “arbitrary, capricious, or manifestly contrary to the statute.” People for the Ethical Treatment of Animals v. United States Dep’t of Agric., 861 F.3d 502, 510

Free access — add to your briefcase to read the full text and ask questions with AI

Fain v. Crouch, (S.D.W. Va. 2021).

Fain v. Crouch (Fain v. Crouch) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

National Federation of Independent Business v. Sebelius
132 S. Ct. 2566 (Supreme Court, 2012)
David King v. Sylvia Burwell
759 F.3d 358 (Fourth Circuit, 2014)
King v. Burwell
135 S. Ct. 2480 (Supreme Court, 2015)
Callum v. CVS Health Corp.
137 F. Supp. 3d 817 (D. South Carolina, 2015)